Royal Bank of Canada
HRMY icon

Royal Bank of Canada’s Harmony Biosciences HRMY Stock Holding History

Royal Bank of Canada’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60K Sell
2,131
-1,233
-37% -$40.4K ﹤0.01% 5394
2025
Q4 		$126K Sell
3,364
-931
-22% -$30.6K ﹤0.01% 5074
2025
Q3 		$118K Buy
4,295
+232
+6% +$7.99K ﹤0.01% 5421
2025
Q2 		$128K Sell
4,063
-14,056
-78% -$452K ﹤0.01% 5475
2025
Q1 		$602K Sell
18,119
-4,200
-19% -$151K ﹤0.01% 3856
2024
Q4 		$768K Buy
22,319
+17,635
+376% +$606K ﹤0.01% 3746
2024
Q3 		$187K Sell
4,684
-7,384
-61% -$259K ﹤0.01% 4869
2024
Q2 		$364K Sell
12,068
-16,317
-57% -$491K ﹤0.01% 4261
2024
Q1 		$953K Sell
28,385
-4,338
-13% -$139K ﹤0.01% 3498
2023
Q4 		$1.06M Buy
32,723
+14,017
+75% +$391K ﹤0.01% 3629
2023
Q3 		$614K Buy
18,706
+6,869
+58% +$238K ﹤0.01% 3865
2023
Q2 		$417K Buy
11,837
+4,063
+52% +$140K ﹤0.01% 4090
2023
Q1 		$254K Sell
7,774
-2,705
-26% -$123K ﹤0.01% 4420
2022
Q4 		$577K Buy
10,479
+4,679
+81% +$257K ﹤0.01% 3984
2022
Q3 		$257K Buy
5,800
+4,983
+610% +$243K ﹤0.01% 4550
2022
Q2 		$40K Sell
817
-1,425
-64% -$64.2K ﹤0.01% 5817
2022
Q1 		$109K Sell
2,242
-2,601
-54% -$106K ﹤0.01% 5590
2021
Q4 		$206K Buy
4,843
+1,586
+49% +$63.2K ﹤0.01% 5307
2021
Q3 		$125K Buy
3,257
+964
+42% +$31K ﹤0.01% 5550
2021
Q2 		$65K Buy
2,293
+1,623
+242% +$48.7K ﹤0.01% 5861
2021
Q1 		$22K Buy
670
+614
+1,096% +$21.5K ﹤0.01% 6367
2020
Q4 		$2K Buy
+56
New +$2.26K ﹤0.01% 6857

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Royal Bank of Canada's HRMY Position: Q1 2026 in Review

Royal Bank of Canada reduced its Harmony Biosciences (HRMY) stake by 37% in Q1 2026, selling an estimated $40.4K and leaving 2,131 shares worth $60K. The position accounts for ﹤0.01% of the portfolio, ranked #5394.

Royal Bank of Canada first reported a position in HRMY in Q4 2020 and has held it in 22 quarters since. The position peaked at $1.06M in Q4 2023. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Royal Bank of Canada held 2,131 shares of Harmony Biosciences worth $60K as of Q1 2026.
  • Royal Bank of Canada sold 1,233 Harmony Biosciences shares in Q1 2026, an estimated $40.4K.
  • Harmony Biosciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5394 holding.
  • Royal Bank of Canada first reported a position in Harmony Biosciences in Q4 2020 and has held it in 22 quarters since.
  • Royal Bank of Canada's Harmony Biosciences position peaked at $1.06M in Q4 2023.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.